How big is the Medical Foods Market?

The Medical Foods Market size is expected to reach USD 10 million in 2024 and grow at a CAGR of 5.30% to reach USD 20 million by 2029. Read More

What is the current Medical Foods Market size?

In 2024, the Medical Foods Market size is expected to reach USD 10 million. Read More

Who are the key players in Medical Foods Market?

Danone S.A., Nestlé S.A., Abbott, Fresenius Kabi AG and Primus Pharmaceuticals Inc. are the major companies operating in the Medical Foods Market. Read More

Which is the fastest growing region in Medical Foods Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Medical Foods Market?

In 2024, the North America accounts for the largest market share in Medical Foods Market. Read More

What years does this Medical Foods Market cover, and what was the market size in 2023?

In 2023, the Medical Foods Market size was estimated at USD 9.47 million. The report covers the Medical Foods Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Medical Foods Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Medical Foods Market Share

Statistics for the 2023 & 2024 Medical Foods market share, created by Mordor Intelligence™ Industry Reports. Medical Foods share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Medical Foods Industry

The medical foods market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. Major players in the market are focused on product launches and advancements to expand their presence in the global market. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Danone SA, Nestlé SA, Abbott, Fresenius Kabi AG, and Primus Pharmaceuticals Inc.